Account Information

bundle-connector

header

secondary-primary-menu

zone2

mega-menu

Browse by Institution Type

Browse by Product Type

Products

Support

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

header-component

cengage:galethorndikeseo

footer-legal-menu-component

secondary-account-menu

footer

footer-social-menu-component

About Us

Blogs

Press Center

Events

News

Careers

Our Company

Request a Trial

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

footer-legal-menu

Terms of use

Privacy

gale-footer

container

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

FIND YOUR REP

support-order-2

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Partnerships

Contact Us

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

config

single-column

footer-menu-component

zone1

zone3

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

Profile

Orders

Wish List

Fast Order Entry

My Account

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

Diseases & Conditions

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.​

Obesity and Breast Cancer

POST SECONDARY FOUR YEAR

COLFR

COLJR

COLSO

COLSR

SBCR: OBESITY & BREAST CANCER

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Other Frontmatter.
Title Page.
Copyright Page.
Acknowledgments.
Contents.
Introduction.
1: Estrogens, Adiposity and the Menopause.
2: The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence.
3: Adipose-Derived and Obesity-Related Factors and Breast Cancer.
4: Estrogen Biosynthesis.
5: Therapy Aimed at Breaking the Linkage between Obesity and Breast Cancer.
Conclusions.
References.

Obesity and Breast Cancer.css-1p8rvzy{position:absolute;padding-left:8px;}

Obesity and Breast Cancer